1. Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial. (November 2022) Authors: Hepprich, Matthias; Mudry, Jonathan M.; Gregoriano, Claudia; Jornayvaz, Francois R.; Carballo, Sebastian; Wojtusciszyn, Anne; Bart, Pierre-Alexandre; Chiche, Jean-Daniel; Fischli, Stefan; Baumgartner, Thomas; Cavelti-Weder, Claudia; Braun, Dominique L.; Günthard, Huldrych F.; Beuschlein, Felix; C... Journal: EClinicalMedicine Issue: Volume 53(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Direct effects of exercise on kynurenine metabolism in people with normal glucose tolerance or type 2 diabetes. Issue 7 (1st May 2016) Authors: Mudry, Jonathan M.; Alm, Petter S.; Erhardt, Sophie; Goiny, Michel; Fritz, Tomas; Caidahl, Kenneth; Zierath, Juleen R.; Krook, Anna; Wallberg‐Henriksson, Harriet Journal: Diabetes/metabolism research and reviews Issue: Volume 32:Issue 7(2016:Oct.) Page Start: 754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗